TYRO3 and neoplasm: The addition of anti–PD-1 significantly increased lipid ROS in 4T1-P, but not in Tyro3-OE tumor cells, supporting the assumption that TYRO3 suppresses anti–PD-1–induced tumor cell ferroptosis.